Metabolism of heptabarbitone
- 1 February 1974
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 26 (2), 123-125
- https://doi.org/10.1111/j.2042-7158.1974.tb09237.x
Abstract
The human metabolism of 5-ethyl-5-cycloheptenylbarbituric acid, heptabarbitone, Medomin, taken orally, has been studied. Comparison of g.c., and g.c.-m.s. data, from derivatized urine extracts, with data from authentic synthetic samples, has shown that 5-(3î-oxocycloheptenyl)-5-ethylbarbituric acid (II) and 5-(3î-hydroxycycloheptenyl)-5-ethylbarbituric acid (III) are major metabolites of heptabarbitone. In addition, similar data have been obtained for a third metabolite. There was no evidence for the presence of the parent drug in the urine of the two volunteers. The rate of urinary excretion of the three metabolites is briefly discussed.Keywords
This publication has 4 references indexed in Scilit:
- Metabolic Fate of Hexobarbital (HBjDrug Metabolism Reviews, 1972
- Combined gas-liquid chromatography—mass spectrometry in the study of barbiturate metabolismJournal of Pharmacy and Pharmacology, 1970
- Metabolic Fate of Drugs: Barbiturates and Closely Related CompoundsAnnual Review of Pharmacology, 1967
- Metabolism of Drugs. VI. The Metabolic Fate of Methylhexabital (5-Cyclohexenyl-3, 5-dimethylbarbituric Acid).(2).3) On the Chromic Oxidation of Methylhexabital and Normethylhexabital (5-Cyclohexenyl-5-methylbarbituric Acid)Pharmaceutical Bulletin, 1956